Resuscitation

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

Retrieved on: 
Friday, March 22, 2024
Cardiac output, U.S. FDA, Internal bleeding, Partnership, System, Patient, Research, Trauma, Diarrhea, Hypovolemic shock, Mortality, Gastrointestinal bleeding, Manuscript, Laboratory, Blood volume, Standard of care, DRUGS, Clinical trial, Resuscitation, Safety, DCGI, Phase, Vomiting, Blood, FDA, Food, Shock (mechanics), Emerging market, Generic drug

Developed by Pharmazz for potential global use, Centhaquine is a resuscitative agent presently indicated for treating hypovolemic shock by Drugs Controller General of India (DCGI).

Key Points: 
  • Developed by Pharmazz for potential global use, Centhaquine is a resuscitative agent presently indicated for treating hypovolemic shock by Drugs Controller General of India (DCGI).
  • As per the agreement, Dr. Reddy's has received exclusive rights to market and distribute Centhaquine in India.
  • For patients with hypovolemic shock, I believe Dr. Reddy's is the best partner for Pharmazz to market Centhaquine, an innovative, first-in-class novel resuscitative agent, in India."
  • U.S. FDA clearance of our Phase III IND is an important milestone for Pharmazz and the potential future treatment of hypovolemic shock patients.

Grant & Eisenhofer Wins Jury Trial in Wrongful Death Suit Against The University of Chicago Medical Center

Retrieved on: 
Wednesday, March 13, 2024
Legal, Hospitals, Neurology, Baby, Maternity, Professional Services, Family, University, Consumer, Health, Education, Blood pressure, Depression, Birth injury, Grief, Cerebral palsy, UCMC, Labour, Bleeding, Abdominal pain, G&E, Death, Grant & Eisenhofer, Resuscitation, Estate, Injury, HIE, Pain, Medicine, Nursing, Delivery, Omotola Jalade Ekeinde, Birth control

Leading plaintiffs’ law firm Grant & Eisenhofer won a jury verdict of over $14 million against The University of Chicago Medical Center, in a wrongful death lawsuit filed on behalf of the estate of a boy who was born at UCMC with catastrophic brain damage.

Key Points: 
  • Leading plaintiffs’ law firm Grant & Eisenhofer won a jury verdict of over $14 million against The University of Chicago Medical Center, in a wrongful death lawsuit filed on behalf of the estate of a boy who was born at UCMC with catastrophic brain damage.
  • James Varga in Cook County Circuit Court (Illinois), a 12-person jury found UCMC liable for the death of four-and-a-half-year-old Oluwasemilore “Praise” Oyedapo.
  • Grant & Eisenhofer represented Praise’s mother, Omotola Oyedapo, who was 33-weeks pregnant when she was brought by ambulance to UCMC on July 9, 2016.
  • The case is captioned: Olusoji Oyedapo, as Independent Administrator of the Estate of Oluwasemilore Praise Oyedapo v. The University of Chicago Medical Center d/b/a UChicago Medicine, 20 L 13797.

Delta Development Team Receives SBIR Phase Two Enhancement for Innovations in Battlefield Blood Storage

Retrieved on: 
Thursday, March 28, 2024
Temperature, APRU, DHA, SBIR, Trauma, App Store (iOS/iPadOS), DDT, Freezing, AFWERX, Resuscitation, TBS, EMS, Multimedia, Blood, FDA, Defense, Small Business Innovation Research, Medical device

For the past five years, DDT has been diligently working on this system, marking it as their third FDA-listed medical device for blood delivery.

Key Points: 
  • For the past five years, DDT has been diligently working on this system, marking it as their third FDA-listed medical device for blood delivery.
  • In Ukraine, the APRU is employed for stabilization during damage control resuscitation, while the Delta Ice is used for drone blood resupply.
  • Furthermore, DDT has developed the Transportable Blood Storage (TBS), a 10-day powered refrigerator designed to increase blood supply capacity on the battlefield.
  • They are proud to have achieved another SBIR (previously awarded the AFWERX Phase I and II) to continue to develop life-saving technology that they are passionate about.

EISENHOWER HEALTH EARNS NATIONAL RECOGNITION WITH HeartCARE CENTER DESIGNATION

Retrieved on: 
Wednesday, February 28, 2024
TAVR, Hospital, BSN, Aortic stenosis, Resuscitation, Registry, RN, Electrophysiology, MBA, Cardiology, Heart failure, NCDR, American College, Patient, MPH, FACC, Disease, Heart, ACC, Coachella Valley, Accreditation, PCI, Nursing

RANCHO MIRAGE, Calif., Feb. 28, 2024 /PRNewswire/ -- The American College of Cardiology has recognized Eisenhower Health for its demonstrated commitment to comprehensive, high-quality culture and cardiovascular care. Eisenhower Health was awarded the HeartCARE Center National Distinction of Excellence based on meeting accreditation criteria, and through their ongoing performance registry reporting.

Key Points: 
  • Eisenhower Health was awarded the HeartCARE Center National Distinction of Excellence based on meeting accreditation criteria, and through their ongoing performance registry reporting.
  • "We are proud to be the Coachella Valley's only heart program to earn the HeartCARE Center distinction.
  • "ACC Accreditation Services is proud to award Eisenhower Health with the HeartCARE Center designation."
  • Eisenhower Health has proven to be a forward-thinking institution with goals to advance the cause of sustainable quality improvement.

Deep Space Healthcare Challenge winner: Addressing medical emergencies in space and on Earth

Retrieved on: 
Wednesday, February 28, 2024
Astronaut, Challenge, Resuscitation, MD, Ageing, Injury, Moon, Privy council, Health, Human, Indigenous Services Canada, Disease, Diagnosis, Environment, Face, Pressure, Medical device

Their EZResus solution is already helping save lives on Earth and holds great potential for diagnosis and medical emergencies in space.

Key Points: 
  • Their EZResus solution is already helping save lives on Earth and holds great potential for diagnosis and medical emergencies in space.
  • The Deep Space Healthcare Challenge was created to support healthcare needs of astronauts in space and, in turn, people living in remote communities.
  • With the Deep Space Healthcare Challenge, we called on Canada's vibrant medical technology sector to explore new ways of contributing to humanity's return to the Moon and the future of deep-space exploration.
  • The Deep Space Healthcare Challenge launched in November 2021 and received 108 applications.

Vivacelle Bio Integrates Sub-Saharan Africa Strategy into Series B Financing Round

Retrieved on: 
Thursday, February 22, 2024
Blood pressure, Blood, School, Sepsis, Woman, IIA, Bleeding, Doctor of Philosophy, Resuscitation, The, Shock, MD, Diarrhea, Temperature, Septic, University, Nitric oxide, Shock (mechanics), Senior advisor, Finger, Life, Urinary tract infection, Risk, Internal bleeding, Pelvic floor dysfunction, Malaria, Hypovolemia, Nanoparticle, Gangrene, Neonatal sepsis, JD, Patient, Septic shock, Clinical trial, UMKC, Child, Reperfusion injury, Hypotension, Partnership

Targeted $20M Series B Round to include Sub-Saharan Africa in product development.

Key Points: 
  • Targeted $20M Series B Round to include Sub-Saharan Africa in product development.
  • Vivacelle Bio is partnering with Propelevate to drive the Sub-Saharan Africa strategy, which is fully integrated into its Series B financing round.
  • Through partnership with Propelevate, Vivacelle Bio will engage global health funders and stakeholders during final stages of product development, and Propelevate will drive Vivacelle Bio's go-to-market strategy for African markets upon regulatory approval.
  • "We are excited to partner with Vivacelle Bio because of their commitment to Sub-Saharan Africa.

IDF and Delta Development Team Forge Strategic Partnership to Enhance Emergency Blood Transfusions on the Frontlines

Retrieved on: 
Tuesday, February 20, 2024
Research, Resuscitation, Multimedia, DOD, Blood, Transport, IDF, DDT, Trauma, EMS, Software, Partnership, Nursing

Understanding the critical significance of rapid access to blood for transfusions, the IDF has embarked on a comprehensive endeavor in collaboration with DDT.

Key Points: 
  • Understanding the critical significance of rapid access to blood for transfusions, the IDF has embarked on a comprehensive endeavor in collaboration with DDT.
  • To tackle this pressing need, the IDF, partnering with DDT, has instituted a specialized training program.
  • These vehicles will be manned by a critical care team comprising BN level medics, ensuring immediate damage control resuscitation on the frontlines.
  • Delta Development Team, Inc. , headquartered in Tucson, Arizona, comprises a dynamic cadre of engineers and visionaries committed to revolutionizing blood storage and transportation solutions.

Unibet and Tour de Tietema launches heart health awareness campaign - 'Follow Your Heart'

Retrieved on: 
Wednesday, February 14, 2024
Resuscitation, TDT, Kindred, Follow Your Heart, Sport, Human, Kindred Group, Survival, Heart, Augmented reality, DNA

VALLETTA, Malta, Feb. 14, 2024 /PRNewswire/ -- Unibet in Belgium and the Netherlands launches a campaign with the Dutch cycling team Tour de Tietema to raise awareness and educate the public about heart health issues within the cycling community.

Key Points: 
  • VALLETTA, Malta, Feb. 14, 2024 /PRNewswire/ -- Unibet in Belgium and the Netherlands launches a campaign with the Dutch cycling team Tour de Tietema to raise awareness and educate the public about heart health issues within the cycling community.
  • The campaign is called 'Follow Your Heart'.
  • Kindred Group plc's (Kindred) flagship brand Unibet has, together with Tour de Tietema (TDT), developed an online learning tool in response to the growing concern over heart health issues within the cycling community.
  • In addition, the cycling team will wear a custom exclusive jersey to draw attention to the importance of heart health.

Unibet and Tour de Tietema launches heart health awareness campaign - 'Follow Your Heart'

Retrieved on: 
Wednesday, February 14, 2024
Resuscitation, TDT, Kindred, Follow Your Heart, Sport, Human, Kindred Group, Survival, Heart, Augmented reality, DNA

VALLETTA, Malta, Feb. 14, 2024 /PRNewswire/ -- Unibet in Belgium and the Netherlands launches a campaign with the Dutch cycling team Tour de Tietema to raise awareness and educate the public about heart health issues within the cycling community.

Key Points: 
  • VALLETTA, Malta, Feb. 14, 2024 /PRNewswire/ -- Unibet in Belgium and the Netherlands launches a campaign with the Dutch cycling team Tour de Tietema to raise awareness and educate the public about heart health issues within the cycling community.
  • The campaign is called 'Follow Your Heart'.
  • Kindred Group plc's (Kindred) flagship brand Unibet has, together with Tour de Tietema (TDT), developed an online learning tool in response to the growing concern over heart health issues within the cycling community.
  • In addition, the cycling team will wear a custom exclusive jersey to draw attention to the importance of heart health.

A new emergency procedure for cardiac arrests aims to save more lives – here’s how it works

Retrieved on: 
Sunday, February 11, 2024
CPR, Hospital, Emergency medical services, Resuscitation, Shock, Heart, Cardiac arrest, Life, Human, Risk, Survival rate, COVID-19, Translation, Patient, Survival, Defibrillation, Ventricular fibrillation, Travel, Medical device

Known as “double sequential external defibrillation” (DSED), it will change initial emergency response strategies and potentially improve survival rates for some patients.

Key Points: 
  • Known as “double sequential external defibrillation” (DSED), it will change initial emergency response strategies and potentially improve survival rates for some patients.
  • Surviving cardiac arrest hinges crucially on effective resuscitation.
  • But if normal electrical rhythms are disrupted, heartbeats can become unco-ordinated and ineffective, or cease entirely, leading to cardiac arrest.

Using two defibrillators

  • A heart expert explains

    DSED is a novel method that provides rapid sequential shocks to the heart using two defibrillators.

  • A single operator activates the defibrillators in sequence, with one hand moving from the first to the second.
  • It delivers more total energy to the heart, travelling along a different pathway closer to the heart’s left ventricle.

Evidence of success

  • Read more:
    Arrested development: Can we improve cardiac arrest survival in hospitals?
  • Though the existing evidence for DSED is compelling, until recently it was based on theory and a small number of potentially biased observational studies.
  • It provides confidence that survival improvements were due to the defibrillation approach and not regional differences in resources and training.
  • A cardiologist explains how they interact with the electrical system of the heart

    The study also corroborates and builds on existing theoretical and clinical scientific evidence.

Training and implementation

  • Although the evidence is still emerging, implementation of DSED by emergency services in New Zealand has implications beyond the care of patients nationally.
  • Here's why they should learn CPR and basic life support

    Before using DSED, emergency medical personnel undergo mandatory education, simulation and training.

  • As part of the implementation, the St John ambulance service will perform case reviews in addition to wider monitoring to ensure patient safety is prioritised.


Vinuli Withanarachchie is a Clinical Research Assistant at Hato Hone St John. Bridget Dicker is Head of Clinical Audit and Research at Hato Hone St John. She is a member of the International Liaison Committee on Resuscitation Basic Life Support (BLS) Task Force. Sarah Maessen is a Clinical Research Fellow at Hato Hone St John.